亚香股份：计划购买美国ABT公司部分股权的事项，目前暂无重大进展

Core Viewpoint - The company has indicated that its plan to acquire a 10% stake in Abbott Laboratories (ABT) is currently facing delays due to policy influences and other objective factors, with no significant progress reported as of now [1] Group 1 - The company previously announced a plan to purchase a 10% stake in ABT for an amount of $30 million [1] - The acquisition process is still undergoing regulatory filing and review, which has led to the current lack of announcements regarding the status [1] - The company has committed to comply with relevant laws and regulations for information disclosure if there are any significant developments in the acquisition process [1]